ADORA2A and early-onset autosomal dominant Alzheimer disease: Inhibition of the A2AR is a well-established mechanism of brain protection against adverse events such as ischemic brain damage, traumatic brain injury, excitotoxicity, and neurodegenerative conditions such as Parkinson’s and Alzheimer’s disease [20,39].